drugset / Trial / NCT03847441

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

NCT03847441

Completed 60 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Alopecia Areata is a common condition. This study investigated the efficacy of calcipotriol versus Narrow Band Ultraviolet B in treatment of Alopecia areata and their effects on serum vitamin D3 levels.

Timeline

Start
2017-10-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule 0.005 % Topical

Indications